Researchers at Japan’s Mie University in Tsu city have made a breakthrough using CRISPR-Cas9 technology to remove the extra chromosome responsible for the condition in lab-grown cells. By precisely targeting and deleting the surplus chromosome 21, they restored normal gene activity and improved cell function.